Procurement Summary
Country: Brazil
Summary: Acquisition of Medicines to Meet the Needs of the Caf - Pharmaceutical Supply Center and Guarantee the Pharmaceutical Assistance Cycle to Sus Users in the Municipality of Macae.
Deadline: 07 Feb 2024
Posting Date: 27 Jan 2024
Other Information
Notice Type: Tender
TOT Ref.No.: 95867660
Document Ref. No.: 90003/2024
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of medicines to meet the needs of the CAF - Pharmaceutical Supply Center and guarantee the Pharmaceutical Assistance Cycle to SUS users in the municipality of Macae.
UASG Code: 927152
Notice from: 26/01 /2024 from 08:00 to 11:59 am and from19981d172c851bd4e8a1788d5726c2d312:00 to 17:59
Proposal Delivery: from 01/26/2024 at 08:00
ZOLEDRONIC ACID, CONCENTRATION 50 MCG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 12
AFLIBERCEPTE, CONCENTRATION 40 MG/ ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS WITH APPLICATION SYSTEM
Quan19981d172c851bd4e8a1788d5726c2d3Quantity: 34
ALOGLIPTIN, COMPOSITION ASSOCIATED WITH PIOGLITAZONE, CONCENTRATION 25 MG 30 MG
Quantity: 338
BISOPROLOL FUMARATE, CONCENTRATION 2.5 MG
Quantity: 338
BUDESONIDE, CONCENTRATION 200 MCG, PHARMACEUTICAL FORM CAPSULE INHALER POWDER, CHARACTER ADDITIONAL ISTIC WITH INHALER
Quantity: 675
CYCLOBE19981d172c851bd4e8a1788d5726c2d3NZAPRINE HYCLORIDATE, DOSAGE 5 MG
Quantity: 338
CHOLESTYRAMINE, DOSAGE 4G, POWDER PRESENTATION
Quantity: 675
MOISTURIZING CREAM, COMPOSITION BASED ON HYALURONIC ACID AND CERAMIDES, ADDITIONAL CHARACTERISTICS* WITHOUT PERFUME
Quantity: 12
DENOSUMAB, CONCENTRATION 60 MG /ML, PHARMACEUTICAL FORM SOLUTION I19981d172c851bd4e8a1788d5726c2d3NJETABLE
Quantity: 12
DULAGLUTIDE, CONCENTRATION 1.5 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS IN FILLED SYRINGE, ADDITIONAL WITH APPLICATION SYSTEM
Quantity: 45
DUPILUMAB, CONCENTRATION 150 MG/ML, PHARMACEUTICAL FORM SOLU INJECTABLE TION, ADDITIONAL FILLED SYRINGE19981d172c851bd4e8a1788d5726c2d3DA
Quantity: 4
ECULIZUMAB, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 68
EDOXABAN, TOSYLATE COMPOSITION, CONCENTRATION 60 MG
Quantity: 338
EMPAGLIFLOZIN, CONCENTRATION 10 MG
Quantity: 338
MEDICAL EXTRACT, COMP OSITION SAFFRON (CURCUMA LONGA), CONCENTRA19981d172c851bd4e8a1788d5726c2d3TIONS 250 MG
Quantity: 338
EZETIMIBA, COMPOSITION ASSOCIATED WITH...
Documents
Tender Notice